Navigation Links
MIGENIX Corporate Update and Requisition of Special Meeting
Date:7/8/2008

at MX-2401 has a good safety profile and very favorable pharmacokinetic and pharmcodymamic properties including a long half-life and efficacy in multiple animal models of infectious diseases, including pneumonia. The features of MX-2401 indicate a highly competitive intravenous agent for treating serious gram positive infections (including the highly publicized resistant bacteria, VRE and MRSA). Activities in the program are currently focused on manufacturing and advancing the program to an IND/CTA for clinical development by late 2009. Advances in manufacturing process development have recently been achieved. We have a $9.3 million investment commitment with Canada Industrial Technologies Office (formerly Technology Partnership's Canada (TPC) program) for the development of this compound.

SB9000 (dinucleotide for Hepatitis B Virus infections): This program was out-licensed to Spring Bank Pharmaceuticals and is currently in pre-clinical development. Spring Bank plans to advance the program into the clinical stage of development in the first quarter of 2010. We have a 1,000,000 convertible preferred share and 50,000 common share ownership position in Spring Bank. Under the terms of a license agreement, MIGENIX can also receive up to US$3.5 million in milestone payments during development of the compound and royalties upon commercialization.

MX-4565 (for neurodegenerative diseases): This pre-clinical program has been supported by a grant from the Michael J. Fox Foundation ("MJFF") awarded to us in June 2007 for research related to Parkinson's and other disease indications. The potential for a second year of funding is under review by MJFF and us. The grant award agreement provides Elan Pharmaceuticals with a limited right to license the technology arising from the MJFF project for certain uses in the field of human disease. Other license discussions for ophthalmologic indications are currently active.

Requisition of Special Shareholder Meeting '/>"/>

SOURCE MIGENIX Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
3. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
4. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
6. MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
7. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
8. MIGENIX releases CEO message #22
9. MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
10. MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results
11. MIGENIX Appoints Pieter Dorsman to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... of a magnet using an electric field (magnetoelectric ... of the next-generation technology for information processing and ... MEM effect, due to the coexistence of electric ... coexistence of spontaneous electric and magnetic polarizations is ... potential of the MEM effect. This article briefly ...
(Date:9/12/2014)... Advancing the front lines of research ... biological threats is the mission of an international ... and the Georgian National Academy of Sciences, and ... Security Programme of the North Atlantic Treaty Organization ... series, the event is titled “Nanotechnology to Aid ...
(Date:9/12/2014)... View, CA (PRWEB) September 12, 2014 ... fundraising campaign on Indiegogo. , The film, directed ... Hawking, Buzz Aldrin, Shimon Peres, Ashton Kutcher, Will.i.Am, Michio ... the world and there’s only one university in the ... to help change the lives of a billion people: ...
(Date:9/12/2014)... Sandia Biotech, Inc. announced today that the company ... for a technology developed by researchers at the University ... Queen Mary University of London in London, England. ... Technology Platform (RFAP) was developed by Dr. Ravi Durvasula ... Kang from Queen Mary’s Department of Molecular Cell Biology, ...
Breaking Biology Technology:Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 2Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 3Documentary Film that Follows Singularity University Students as They Change the World Launches its IndieGoGo Fundraising Campaign 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 4
... May 21 Oncolab, Inc.,s AMAS(R) Test,( http://www.oncolabinc.com ... may,allow early detection of a wide range of ... Anti-malignin antibody, in human,serum., Anti-malignin is a ... to,increase with age, as the risk of cancer ...
... ERES ), a leading provider of centralized,electrocardiographic ... Michael J. McKelvey, the Company,s President and,Chief Executive ... are scheduled to present at the FBR 12th ... May 28, 2008 at the Grand Hyatt Hotel ...
... Calif., May 20 NASA has,developed a revolutionary ... bacteria, viruses and parasites. This biosensor,will be used ... biohazards in,water, food and other contaminated sources., ... California licensed the,biosensor technology to Early Warning Inc., ...
Cached Biology Technology:eResearchTechnology to Present at the FBR 12th Annual Spring Investor Conference on May 28th 2008 2NASA Nanotechnology-Based Biosensor Helps Detect Biohazards 2
(Date:9/15/2014)... tip the balance between ridding the body of a ... a report appearing in The Journal of ... viruses cause chronic infections in roughly three-quarters of infected ... diseases including cirrhosis and cancer. A few patients successfully ... CD8 + T cells. The protective effects of ...
(Date:9/15/2014)... reports about the need for vitamin E and how ... that adequate levels of this essential micronutrient are especially ... who are or may become pregnant. , A lifelong ... said, but often complicated by the fact that this ... through diet alone. It has been estimated that only ...
(Date:9/15/2014)... , Sept. 15, 2014  GENiSYSS, a ... , announces the public launch of their ... unique, patented product, combining room temperature, long-term storage ... only company to make personal storage of DNA ... - http://photos.prnewswire.com/prnh/20140912/145664   Photo - http://photos.prnewswire.com/prnh/20140912/145665 ...
Breaking Biology News(10 mins):Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3GENiSYSS Launches Website about Easy, Inexpensive Home DNA Storage for Everyone 2
... PhD, chair of NJIT,s Department of Engineering Technology, has ... Engineering Education (ASEE). Rockland, of Parsippany, will receive ... June in Canada. Rockland,s career began in 1970 ... Beth Israel Medical Center. Since then he has ...
... -- Fables have long cast scorpions as bad-natured killers of ... Michigan State University scientists, however, see them in a different ... the effects of scorpion venom with the hopes of finding ... are published in the current issue of the Journal ...
... courtship antics likely influence their success at attracting and ... Roz Dakin and Robert Montgomerie have found that ... peacock,s tail does not impact a male,s mating success. ... the number of eyespots are less successful at mating. ...
Cached Biology News:Engineering education society names NJIT professor Fellow 2For peacocks, the eyespots don't lie 2
Request Info...
... polyacrylamide gel electrophoresis (2D-PAGE) with biological mass ... technology platform for proteomic analysis. 2D-PAGE gels ... limited only in the dynamic range and ... Quantitative image based analysis of separated proteins ...
... DNA Polymerase is ideal for high-fidelity ... applications such as cloning and mutagenesis. ... a proprietary enzyme preparation containing recombinant ... proofreading (3'Cut Site5' exonuclease) activity. ...
... N-term Antibody This antibody is generated from ... peptide selected within aa 50~150 of human ... PBS with 0.09% (W/V) sodium azide. This ... column and eluted out with both high ...
Biology Products: